Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Treatment characteristics in a cohort of patients with hereditary transthyretin amyloidosis

              Author:Qarni, Taha   Sarmiento Bustamante, Nicolas   Simoes Jones, Felipe   Khella, Sami   Drachman, Brian   Pieretti, Janice   Karam, Chafic   

              Session Name:S7: Outcome Measures and Observational Studies of Neuromuscular Diseases  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:S7.010  

              Author Institution:University of Pennsylvania, Philadelphia, PA  Department of Neurology, University of Pennsylvania, Philadelphia, PA  Presbyterian Med Ctr/Dept of Neuro, Philadelphia, PA  

              NfL Levels Significantly Decrease in Response to Treatment with Patisiran or Vutrisiran in hATTR Amyloidosis with Polyneuropathy

              Author:Polydefkis, Michael   Aldinc, Emre   Nienhuis, Hans   Karam, Chafic   Ajroud-Driss, Senda   Sekijima, Yoshiki   Waddington-Cruz, Marcia   Barnes, Jennifer   Nioi, Paul   Ticau, Simina   

              Session Name:S14: General Neurology: Emerging Therapies  

              Topic:General Neurology  

              Program Number:S14.001  

              Author Institution:Johns Hopkins University School of Medicine, Baltimore, MD  Alnylam Pharmaceuticals, Cambridge, MA  Amyloidosis Centre of Expertise, University of Groningen, Groningen, Netherlands  University of Pennsylvania, Philadelphia, PA  Northwestern University Feinberg School of Medicine, Chicago, IL  Shinshu University School of Medicine, Matsumoto , Japan  CEPARM, National Amyloidosis Referral Center, University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil  

              The Bruton’s Tyrosine Kinase Inhibitor Evobrutinib Demonstrates Superior Efficacy in Targeting Compartmentalized Neuroinflammation Compared to Anti-CD20 Treatment.

              Author:Kebir, Hania   Li, Cen   May, Michael   Church, Molly   Boschert Shafaatian, Ursula   Alvarez, Jorge   

              Session Name:S16: MS Clinical Trials and Therapeutics  

              Topic:MS and Inflammatory Disease  

              Program Number:S16.004  

              Author Institution:University of Pennsylvania, Philadelphia, PA  C/o Serono, Geneva, Switzerland  University of Pennsylvania, Philadelpha, PA  

              Prediction of Regional Tau Spread Using Individualized Tau Epicenters and Structural Connectomes

              Author:Brown, Christopher   Das, Sandhitsu   Nasrallah, Ilya   Detre, John   Yushkevich, Paul   McMillan, Corey   Wolk, David   

              Session Name:S39: Neurobiology of Dementia  

              Topic:Aging and Dementia  

              Program Number:S39.002  

              Author Institution:Hospital of the University of Pennsylvania, Philadelphia, PA  University of Pennsylvania, Philadelphia, PA  Hosp of the Univ of Penn, Philadelphia, PA  

              Mortality and functional outcomes in patients with post-stroke epileptic seizures: a systematic review and meta-analysis

              Author:Misra, Shubham   Vazquez, Juan   Eldem, Ece   Silva, Lucas Scardua   Mohidat, Saba   Hickman, L. Brian   Khan, Erum   Funaro, Melissa   Yasuda, Clarissa   Liebeskind, David   Kasner, Scott   Mishra, Nishant K.   

              Session Name:S45: Cerebrovascular Disease and Interventional Neurology: Meta-analyses and Outcomes Research  

              Topic:Cerebrovascular Disease and Interventional Neurology  

              Program Number:S45.006  

              Author Institution:Yale University, New Haven, CT  Albert Einstein College of Medicine, Bronx, NY  University of Campinas, Sao Paulo, Brazil  The Royal Melbourne Hospital, Melbourne, Australia  University of California Los Angeles, Los Angeles, CA  B.J.Medical College,Ahmedabad, Bharuch, India  University of Pennsylvania, Philadelphia, PA